跳至主要内容
临床试验/ITMCTR2100004926
ITMCTR2100004926尚未招募1 期

Efficacy and safety of Yifei Sanjie Recipe combined with anlotinib in the treatment of the second line or above IIIB-IVB non-small cell lung cancer patients: a pilot study

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. Pathologically and/or cytologically diagnose with IIIB-IVB non-small cell lung cancer;
  • 2. Patients with negative driver genes who have received at least one type of systemic chemotherapy (including combined immune checkpoint inhibitors or anti-vascular drug therapy) have progressed, relapsed, or become intolerable; Patients with positive driver gene (EGFR mutation or ALK fusion positive) who have progressed, relapsed, or become intolerable after receiving corresponding standard targeted drug therapy;
  • 3. Aged from 18 to 75 years, male or female;
  • 4. Eastern Cooperative Oncology Group (ECOG) performance scale (PS) score of 0-2;
  • 5. The expected survival time>=24 weeks;
  • 6. A measurable lesion based on the RECIST criteria;
  • 7. Adequate liver and kidney function (creatinine clearance rate>=60ml/min; total bilirubin<=1.5xULN; alanine aminotransferase, aspartate aminotransferase<=2.5xULN));
  • 8. Hemoglobin>100g/L, platelet count>100x10^9/L, neutrophils>1.5x10^9/L;
  • 9. Agree to contraception during the trial and within six months after the trial ends;
  • 10. Patients or their family members signed the informed consent.

排除标准

  • 1. With unstable brain metastases or at risk of bleeding after being evaluated by researchers;
  • 2. Previously used anlotinib or apatinib;
  • 3. Concomitant with other types of malignant tumors;
  • 4. Difficulties with oral medications (such as dysphagia, chronic diarrhea, and intestinal obstruction);
  • 5. Female patients with positive pregnancy test results 7 days before enrollment;
  • 6. Women who are pregnant or breastfeeding;
  • 7. Patients with mental illness or mental retardation;
  • 8. Allergy or intolerance to the study drug.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

相似试验